Biomedica Unveils Next-Generation AI Precision Medicine Portfolio Forging Asia’s Most Comprehensive AI-Driven Smart Healthcare Ecosystem

Biomedica, Asia’s leading innovator in AI-based osteoporosis and sarcopenia screening, is showcasing a full lineup of next-generation precision medicine solutions at the 2025 Health Care Expo Taiwan (Dec 4–7), held at the Nangang Exhibition Center (Hall 1, 4F, Booth M1022). This year marks Biomedica’s largest and most advanced presence to date, underscoring the company’s strategic leadership across AI imaging, precision diagnostics, and smart clinical automation.

Biomedica’s flagship AIXA® AI diagnostic suite—covering osteoporosis, sarcopenia, and vertebral compression fractures—leverages a single X-ray image to generate automated quantitative reports within six seconds. AIXA® supports rapid pre-operative and post-operative risk assessment and enhances workflow efficiency across clinical settings. Extending this innovation, AIXA® on Chip integrates Biomedica’s AI models directly into NVIDIA high-performance modules, enabling plug-and-play AI functionality for X-ray and CT systems and opening a new generation of AI-native imaging devices.

To support home-based care, long-term care, and preventive health markets, Biomedica is introducing its Portable AI X-ray System for rapid deployment of mobile imaging services. Complementing this, MedKEY provides medical-grade speech recognition, identity verification, and behavior-tracking capabilities—serving as a smart process engine for hospitals, clinics, and pharmacies.

In precision oncology, Biomedica and Illumina jointly present the AMG Intelligent NGS Platform, a fully automated solution that integrates AI analytics, digital-twin health modeling, and intelligent laboratory workflows. The platform spans sample preparation, sequencing, and clinical interpretation. Biomedica also debuts LateMei, an AI laboratory assistant that demonstrates high-throughput, automation-ready operation for clinical NGS environments.

To accelerate the development of a unified smart healthcare ecosystem, Biomedica collaborates with a strategic network of global partners, including NTT DATA Taiwan, HPE, Laigo, Taiwan Mobile, and AUO.
• NTT DATA Taiwan provides a secure and scalable medical data transaction and interoperability framework.
• HPE, powered by ProLiant Compute Gen12, enables large-scale NGS processing and clinical-grade AI deployment.
• Keypasco and Taiwan Mobile jointly deliver portable AI X-ray and MedKEY ASR/identity-verification integration.
• AUO showcases next-generation Micro LED transparent displays that present AIXA and AMG diagnostic insights with exceptional clarity, low reflection, and a seamless spatial experience—dramatically enhancing both technological presence and clinical feasibility.

With its expanding AI portfolio and deep international collaborations, Biomedica is setting the pace for the future of precision medicine and smart clinical workflows across Asia—advancing its vision to build the region’s most complete AI-powered healthcare ecosystem.

Ref: https://money.udn.com/money/story/5724/9180280